在西班牙采购器官

R Matesanz

Lancet (London, England)

|September 19, 1992

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

About the Opt-Out System, Live Transplantation, and Information to the Public on Organ Donation in Spain … Y olé!

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

How Spain Reached 40 Deceased Organ Donors per Million Population.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results.

Transplantation proceedings·2016

Same author

End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation.

Medicina intensiva·2016

Same author

Controlled Donation After Circulatory Determination of Death in Spain.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Same author

[Liver and intestinal transplant in paediatric population].

Anales de pediatria (Barcelona, Spain : 2003)·2015

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

在西班牙采购器官

相关概念视频

About the Opt-Out System, Live Transplantation, and Information to the Public on Organ Donation in Spain … Y olé!

How Spain Reached 40 Deceased Organ Donors per Million Population.

Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results.

End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation.

Controlled Donation After Circulatory Determination of Death in Spain.

[Liver and intestinal transplant in paediatric population].

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

相关实验视频

在西班牙采购器官

相关概念视频

About the Opt-Out System, Live Transplantation, and Information to the Public on Organ Donation in Spain … Y olé!

How Spain Reached 40 Deceased Organ Donors per Million Population.

Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results.

End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation.

Controlled Donation After Circulatory Determination of Death in Spain.

[Liver and intestinal transplant in paediatric population].

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.